UVADEX DIN 02406233
Status: Marketed
Holder: THERAKOS LLC
Health Canada record
| Active ingredient(s) | METHOXSALEN 20 MCG |
|---|
| Dosage form | Solution |
|---|
| Route | Extracorporeal |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | D05BA02 METHOXALEN, SYSTEMIC |
|---|
| Original market date | 09-Dec-2013 |
|---|
| Current status date | 09-Dec-2013 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHOXSALEN
| DIN | Product | Company | Form | Strength | Status |
|---|
| 01946374 | OXSORALEN CAP 10MG | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Capsule | METHOXSALEN 10 MG | Cancelled Post Market |
| 01907476 | OXSORALEN LOT 10MG/ML | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Lotion | METHOXSALEN 10 MG | Cancelled Post Market |
| 00252654 | OXSORALEN-ULTRA CAP 10MG | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Capsule | METHOXSALEN 10 MG | Cancelled Post Market |
| 00698059 | ULTRA MOP LOTION 1% | CANDERM G.P. | Liquid | METHOXSALEN 1 % | Cancelled Post Market |
| 00646237 | ULTRAMOP CAP 10MG | CANDERM G.P. | Capsule | METHOXSALEN 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 14356 | 2013-05-09 | New Drug Submission (NDS) | |
International API supply for METHOXSALEN
2 active FDA Drug Master Files.
Request a quote for UVADEX
How to read a Canadian DIN record